These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38245705)

  • 21. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
    Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Hashino K; Ishii M; Iemura M; Akagi T; Kato H
    Pediatr Int; 2001 Jun; 43(3):211-7. PubMed ID: 11380911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. School-aged children with Kawasaki disease: high incidence of cervical lymphadenopathy and coronary artery involvement.
    Fan PC; Chiu CH; Yen MH; Huang YC; Li CC; Lin TY
    J Paediatr Child Health; 2003; 39(1):55-7. PubMed ID: 12542814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease.
    Lim YJ; Jung JW
    Yonsei Med J; 2014 Sep; 55(5):1260-6. PubMed ID: 25048483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe Hemolytic Anemia Following Intravenous Immunoglobulin in an Infant With Kawasaki Disease.
    Tocan V; Inaba A; Kurano T; Sonoda M; Soebijanto K; Nakayama H
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e100-e102. PubMed ID: 27879540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemolytic anemia associated with intravenous immunoglobulin.
    Wilson JR; Bhoopalam H; Fisher M
    Muscle Nerve; 1997 Sep; 20(9):1142-5. PubMed ID: 9270670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
    Platt B; Belarski E; Manaloor J; Ofner S; Carroll AE; John CC; Wood JB
    JAMA Netw Open; 2020 Jan; 3(1):e1918565. PubMed ID: 31899532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.
    Kimura M; Harazaki M; Fukuoka T; Asakura I; Sakai H; Kamimaki T; Ohkawara I; Akiyama N; Tsurui S; Iwashima S; Shimomura M; Morishita H; Meguro T; Seto S
    Pediatr Int; 2017 Apr; 59(4):397-403. PubMed ID: 27743415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of glucocorticoids in Kawasaki disease.
    Miura M
    Int J Rheum Dis; 2018 Jan; 21(1):70-75. PubMed ID: 29105310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial.
    Lin SY; He L; Xie LP; Wang Y; Lin YX; Cao YY; Yan WL; Liu F; Huang GY
    Trials; 2021 Dec; 22(1):898. PubMed ID: 34895290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M; Matsuoka M; Kohno K; Ohki H; Yoshiba S
    Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study.
    Teraguchi M; Ogino H; Yoshimura K; Taniuchi S; Kino M; Okazaki H; Kaneko K
    Pediatr Cardiol; 2013 Apr; 34(4):959-63. PubMed ID: 23184018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
    Kobayashi T; Kobayashi T; Morikawa A; Ikeda K; Seki M; Shimoyama S; Ishii Y; Suzuki T; Nakajima K; Sakamoto N; Arakawa H
    J Pediatr; 2013 Aug; 163(2):521-6. PubMed ID: 23485027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin failure and retreatment in Kawasaki disease.
    Durongpisitkul K; Soongswang J; Laohaprasitiporn D; Nana A; Prachuabmoh C; Kangkagate C
    Pediatr Cardiol; 2003; 24(2):145-8. PubMed ID: 12457253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of IVIG.
    Goto R; Inuzuka R; Shindo T; Namai Y; Oda Y; Harita Y; Oka A
    Clin Rheumatol; 2020 Dec; 39(12):3747-3755. PubMed ID: 32458247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y
    Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
    Tavli V; Yilmazer MM; Güven B; Meşe T; Oner T; Demirpençe S
    Turk Kardiyol Dern Ars; 2010 Jan; 38(1):20-4. PubMed ID: 20215838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.